Arthur G. Lipman, Pharm.D. - International Association for Hospice ...

Arthur G. Lipman
Page 10
Abstracts - continued
25. Lipman AG. The formulary review process in the current fiscal environment. Abstracts of the 45th Annual Meeting,
American Society of Hospital Pharmacists, San Francisco, CA, 1988.
26. Lipman AG, Czajkowski LA. Pharmacological and psychological considerations in the management of prostatic cancer pain.
Abstracts of the Western USA Pain Society Annual Meeting, Santa Fe, NM, 1988.
27. Church RM, Lipman AG, Herrier RN, Smith EB, Boyce RW, Dwight V. Development and implementation of standards of
practice for a multiple institution system of hospitals and ambulatory care centers. Abstracts of the 24th ASHP Midyear
Clinical Meeting, American Society of Hospital Pharmacists, Atlanta, Georgia, 1989.
28. Lipman AG. Process and outcomes of comprehensive medication histories in chronic pain patients, Abstracts of the Western
USA Pain Society Annual Meeting, Park City, UT, 1990.
29. Lipman AG, Twycross RG, Cleeland C, Johns S. A system for concurrent data collection and retrospective analysis of
advanced cancer pain and its management, Pain 1990; Suppl 5:S374.
30. Lipman AG, Berry JI. Role of the Hospice Pharmacist, Abstracts of the 139th Annual Meeting, American Pharmaceutical
Association, San Diego, California, 1992.
31. Lipman AG. New Directions in Pain Management, International Pharmaceutical Abstracts, 1993;30:1145.
32. Lipman AG. The cornerstone of the team approach: a case for better pain management. American Academy of Physician
Assistants Annual Conference Abstracts, 1995.
33. Lipman AG. Adjunctive analgesic drugs in the elderly, Abstracts of the American Society of Consultant Pharmacists Annual
Meeting 1995 Educational Sessions, 1995:97.
34. Lipman AG. Pain management: pharmacoeconomic and clinical outcomes, Abstracts of the Academy of Managed Care
Pharmacy Annual Meeting, 1996.
35 Lipman AG. Evidence -based drug therapy symptom control guidelines for palliative care. J Pain Symptom Manage
1998;15:S:5.
36. Lipman AG. Cancer Pain Management: Pharmacist Knowledge and Practices. American Pain Society 1998 Annual Meeting
Abstracts: 613.
37. Lipman AG, Tyler LS, Jackson II KC. Evidence-based, Drug Therapy Symptom Control Guidelines for Palliative Care. J
Palliative Med. 1999:2:247
38. Jacobson JA, Lipman AG, Beck SL. A Successful Statewide Collaboration to Improve End of Life Care. J Palliative Med.
1999:2:252.
40. Oderda GM, Evans RS, Lloyd J, Lipman AG, Ashburn MA, Chen C, Burke J, Samore M. Cost of opioid-related adverse drug
events in surgical patients. Intern Pharm Abstr. 2001; 38(21):37
41. Oderda GM, Lipman AG, Ashburn MA, Stockdale W. Use of the TOPS as a Pain-Specific HRQOL Instrument, Value in
Health. 2002: 5(6):511.
42. Lipman AG, Dalpiaz A, Lorden SP. Topical lidocaine patch therapy for myofascial pain. J Pain 2002;3 (Suppl 1):46
43. Fakata KL, Lipman AG, Mullin S. Systematic Review of the Effects of Opioids and Pain on Human Immune Function. J Pain
2003;4: Suppl 1:56.
44. Oderda L, Stockdale W, Oderda G, Donaldson G, Ashburn, M, Brixner D, Lipman A. Age and gender-stratified differences in
quality of life in elderly chronic pain patients. Value in Health 2003; 6(3):284.
45. Fakata KL, Lipman AG, Tuteja A, Ho, MJ. Opioid-Induced Bowel Dysfunction: A survey of prevalence and risk factors in
Chronic Non-Malignant Pain Patients, .J Pain. 2004; 5(Suppl 1):45.
46. Tuteja AK, Stockdale B, Ho MJ, Biskupiak J, Fang JC, Lipman AG. Prevalence and Risk Factors of Opioid-Induced Bowel
Disorders. Neurogastroenterol Motil 2004; 16(5):658.
47. Wittink H, Rogers W., Lipman AG, et al. Older and younger adults in pain management programs in the United States:
differences and similarities, J Pain. 2005;6 (Suppl 1):S72.
48. Thomas J, Lipman AG, Slatkin N, et al. A phase III double-blind, controlled trial of methylnaltrexone (MNTX) for opioidinduced
constipation in advanced medical illness, J Clin Oncol. 2005;23 (16S Suppl):LBA8003.
49. Lipman AG, Jackson KC, Stockdale W, Oderda GM. The Treatment Outcomes of Pain Survey (TOPS): a validated healthrelated
quality of life outcomes instrument for research and practice. Proceedings of the 10 th World Congress on Pain, Seattle
WA, International Association for the Study of Pain 2005.
50. Jackson, KC, Lipman AG, Oberg B, Oderda G. health-related quality of life for chronic pain patients: a two year analysis of
the Treatment Outcomes of Pain Survey (TOPS) J Pain 2006;7(Suppl 2): S:84.
51. Lipman AG. Discussion and debate about current QUIPS and IPR findings - where do we go now Abstracts of the 13 th
World Congress on Pain, Glasgow Scotland, August 2006. Seattle. International Association for the Study of Pain, 2007..
52. Zhukovsky D, Thomas J, Lipman AG, Slatkin N. Treatment of opioid-induced constipation with methylnaltrexone in patients
with CNS metastases. Supportive Care in Cancer. 2007;15(6)